Civic Intelligence

Benign Essential Blepharospasm Research Foundation Inc.

990 • Fiscal year 2012 • EIN 74-2193322

Jan 01, 2012 to Dec 31, 2012

Beaumont, TX
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

14th percentile

0.00x

Higher debt load relative to assets than 14% of similar nonprofits.

2012 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2012

Liabilities / Revenue

16th percentile

0.00x

Higher debt load relative to revenue than 16% of similar nonprofits.

2012 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2012

Net Margin

94th percentile

57%

Higher net margin than 94% of similar nonprofits.

2012 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2012

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2012

Asset Growth

85th percentile

22%

Faster asset growth than 85% of similar nonprofits.

2012 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2011 to 2012

Revenue Growth

95th percentile

139%

Faster revenue growth than 95% of similar nonprofits.

2012 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2011 to 2012

Assets

Up

$1,819,053

Up $329,835 (+22%) from 2011

Net Assets

Up

$1,817,651

Up $329,749 (+22%) from 2011

Liabilities

Up

$1,402

Up $86 (+6.5%) from 2011

Revenue

Up

$573,644

Up $333,940 (+139%) from 2011

Expenses

Down

$243,891

Down $9,221 (-3.6%) from 2011

Net Income

Up

$329,753

Up $343,161 (+2559%) from 2011

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$3.0M$2.0M$1.0M$0Assets 2011: $1,489,218Liabilities 2011: $1,316Net Assets 2011: $1,487,9022011Assets 2012: $1,819,053Liabilities 2012: $1,402Net Assets 2012: $1,817,6512012Assets 2013: $1,680,190Liabilities 2013: $1,375Net Assets 2013: $1,678,8152013Assets 2014: $1,509,705Liabilities 2014: $1,325Net Assets 2014: $1,508,3802014Assets 2015: $1,558,261Liabilities 2015: $3,425Net Assets 2015: $1,554,8362015Assets 2016: $1,593,562Liabilities 2016: $4,926Net Assets 2016: $1,588,6362016Assets 2017: $1,734,958Liabilities 2017: $2,997Net Assets 2017: $1,731,9612017Assets 2018: $1,579,461Liabilities 2018: $1,841Net Assets 2018: $1,577,6202018Assets 2019: $1,580,335Liabilities 2019: $2,656Net Assets 2019: $1,577,6792019Assets 2020: $1,500,213Liabilities 2020: $2,045Net Assets 2020: $1,498,1682020Assets 2021: $1,823,419Liabilities 2021: $2,113Net Assets 2021: $1,821,3062021Assets 2022: $1,832,628Liabilities 2022: $1,760Net Assets 2022: $1,830,8682022Assets 2024: $2,691,107Liabilities 2024: $4,779Net Assets 2024: $2,686,3282024

Highlighted filing

2012

Assets$1,819,053
Liabilities$1,402
Net Assets$1,817,651

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2011: $239,704Expenses 2011: $253,112Net Income 2011: -$13,4082011Revenue 2012: $573,644Expenses 2012: $243,891Net Income 2012: $329,7532012Revenue 2013: $275,714Expenses 2013: $414,553Net Income 2013: -$138,8392013Revenue 2014: $237,862Expenses 2014: $408,298Net Income 2014: -$170,4362014Revenue 2015: $229,612Expenses 2015: $181,169Net Income 2015: $48,4432015Revenue 2016: $215,609Expenses 2016: $169,483Net Income 2016: $46,1262016Revenue 2017: $395,223Expenses 2017: $256,987Net Income 2017: $138,2362017Revenue 2018: $248,139Expenses 2018: $360,946Net Income 2018: -$112,8072018Revenue 2019: $264,958Expenses 2019: $327,096Net Income 2019: -$62,1382019Revenue 2020: $174,275Expenses 2020: $292,130Net Income 2020: -$117,8552020Revenue 2021: $511,633Expenses 2021: $202,844Net Income 2021: $308,7892021Revenue 2022: $370,429Expenses 2022: $223,613Net Income 2022: $146,8162022Revenue 2024: $809,169Expenses 2024: $244,743Net Income 2024: $564,4262024

Highlighted filing

2012

Revenue$573,644
Expenses$243,891
Net Income$329,753
Filing Detail Status

This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview

Mission

Education and research pertaining to benign essential blepharospasm and related conditions

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings